Applied DNA Sciences Inc
NASDAQ:APDN

Watchlist Manager
Applied DNA Sciences Inc Logo
Applied DNA Sciences Inc
NASDAQ:APDN
Watchlist
Price: 3.09 USD 3% Market Closed
Market Cap: 4m USD

Net Margin
Applied DNA Sciences Inc

-2 047.4%
Current
-380%
Average
1%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-2 047.4%
=
Net Income
-67.5m
/
Revenue
3.3m

Net Margin Across Competitors

No Stocks Found

Applied DNA Sciences Inc
Glance View

Applied DNA Sciences, Inc. engages in the developing and marketing DNA-based technology solutions utilizing LinearDNA, large-scale polymerase chain reaction (PCR) based manufacturing platform. The company is headquartered in Stony Brook, New York and currently employs 78 full-time employees. The company went IPO on 2001-08-24. The firm is utilizing its LinearDNA large-scale polymerase chain reaction (PCR) based manufacturing platform. The Company’s proprietary platform produces large quantities of DNA for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets and for supply chain security, anti-counterfeiting and anti-theft technology purposes. Applied DNA also develops PCR-based molecular in vitro diagnostics for covid-19. In addition, under its wholly owned subsidiary, Applied DNA Clinical Labs, LLC, the Company is offering a high-throughput turnkey solution for population-scale Covid-19 testing marketed as safeCircle. safeCircle utilizes the Company’s Covid-19 Diagnostic Tests and is designed to look for infection within defined populations or communities utilizing high throughput testing methodologies.

APDN Intrinsic Value
23.22 USD
Undervaluation 87%
Intrinsic Value
Price
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-2 047.4%
=
Net Income
-67.5m
/
Revenue
3.3m
What is the Net Margin of Applied DNA Sciences Inc?

Based on Applied DNA Sciences Inc's most recent financial statements, the company has Net Margin of -2 047.4%.

Back to Top